Drug Pipeline

CAM2029 Clinical Trials

Name: CAM2029 clinical trials — 3 active studies
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Phase 3

Top Sponsors

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-06-05	NCT07583563 An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly	Trial sites expanded: 0 -> 4 locations
2026-06-05	NCT07583563 An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly	date change Primary completion pushed: 2029-05 -> 2029-06
2026-06-05	NCT07583563 An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly	date change Completion pushed: 2029-05 -> 2029-06

Active Studies by Phase

Phase 3

Phase 2/3

Not specified

Active Trials

NCT ID	Title	Condition	Status
Phase 3
NCT05050942	A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With…	Gastro-enteropancreatic Neuroendocrine Tumor	Active, Not Recruiting
Phase 2/3
NCT05281328	A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients…	Polycystic Liver Disease	Active, Not Recruiting
Not specified
NCT07583563	An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly	Acromegaly	Not Yet Recruiting

Sponsors Running CAM2029 Trials

Camurus AB (3)

Get alerts when CAM2029 trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.